ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2009;87:977-984. doi:10.1016/j.athoracsur.2008.08.018
© 2009 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shanda H. Blackmon
David C. Rice
Reza Mehran
Jon-Cecil Walkes
Garrett L. Walsh
Harsh Singh
Ara A. Vaporciyan
Michael Reardon
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackmon, S. H.
Right arrow Articles by Reardon, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Blackmon, S. H.
Right arrow Articles by Reardon, M.
Related Collections
Right arrow Lung - other

Review

Management of Primary Pulmonary Artery Sarcomas

Shanda H. Blackmon, MD, MPHa,b,c,d,*, David C. Rice, MMB, BChc, Arlene M. Correa, PhDc, Reza Mehran, MDc, Joe B. Putnam, MDc, W. Roy Smythe, MDc, Jon-Cecil Walkes, MDb,d, Garrett L. Walsh, MDc, Cesar Moran, MDc, Harsh Singh, MDe, Ara A. Vaporciyan, MDc, Michael Reardon, MDb,d

a The Methodist Hospital, Department of Surgery, MD Anderson Cancer Center, Houston, Texas
b The Methodist DeBakey Heart Center, MD Anderson Cancer Center, Houston, Texas
c The University of Texas MD Anderson Cancer Center, Houston, Texas
e Christchurch, Canterbury, New Zealand
d Weill Medical College of Cornell University, New York, New York

* Address correspondence to Dr Blackmon, 6550 Fannin St, Smith Tower Ste 1661, Houston, TX 77030 (Email: shblackmon{at}tmhs.org).

The objective of this review is to determine the outcome of patients with sarcomas involving the main pulmonary artery, pulmonic valve, or right ventricular outflow tract. Survival data were analyzed using an aggregate series derived from the published literature in conjunction with a current series. Median survival was 36.5 ± 20.2 months for patients undergoing an attempt at curative resection compared with 11 ± 3 months for those undergoing incomplete resection. Median survival was 24.7 ± 8.5 months for patients undergoing multimodality treatment compared with 8.0 ± 1.7 months for patients having single-modality therapy. A complete review of diagnosis, evaluation, treatment, and surveillance of primary pulmonary artery sarcomas follows.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.